Measurement of lactose crystallinity using Raman spectroscopy.

Raman spectroscopy (RS) was used to determine the crystallinity of lactose (a commonly used carrier in dry powder inhaler (DPI) formulations). Samples of alpha-lactose monohydrate and amorphous lactose were prepared using ethanol precipitation and lyophilisation respectively. The anomeric forms were confirmed using DSC at a rate of 10 degrees C/min and heated to 250 degrees C. The Raman spectra of both alpha-lactose monohydrate and amorphous lactose were obtained. Distinguishable differences were seen between the two spectra including peak areas and intensities. Depolarisation ratios (rho) of each form were then determined to identify the crystallinity of the lactose carrier samples. At the prominent Raman bands 865 and 1082 cm-1, significant differences in rho values were observed for crystalline (0.80+/-0.07, 0.89+/-0.06 respectively) and amorphous samples (0.44+/-0.07, 0.51+/-0.10).

[1]  E. Spinner.  Raman-spectral depolarisation ratios of ions in concentrated aqueous solution. The next-to-negligible effect of highly asymmetric ion surroundings on the symmetry properties of polarisability changes during vibrations of symmetric ions. Ammonium sulphate and tetramethylammonium bromide. , 2003, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[2]  Wolfgang Kiefer,et al.  Identification and characterization of pharmaceuticals using Raman and surface‐enhanced Raman scattering , 2004 .

[3]  N. Corzo,et al.  Changes in anomeric composition of different crystalline forms of lactose during thermal treatment , 1984 .

[4]  G. P. Martin,et al.  Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  G. Regdon,et al.  Quantitative Determination of Crystallinity of α-Lactose Monohydrate by DSC , 2002 .

[6]  K. Gordon,et al.  Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysis. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[8]  Sergei G. Kazarian,et al.  Polymorphism and devitrification of nifedipine under controlled humidity: a combined FT‐Raman, IR and Raman microscopic investigation , 2004 .

[9]  M S Kemper,et al.  Application of diffuse reflectance near-infrared spectroscopy for determination of crystallinity. , 2000, Journal of pharmaceutical sciences.

[10]  G P Martin,et al.  The influence of carrier morphology on drug delivery by dry powder inhalers. , 2000, International journal of pharmaceutics.

[11]  C. Beevers,et al.  The structure of a-lactose monohydrate , 1971 .

[12]  Robin J. H. Clark,et al.  Raman microscopy in archaeological science , 2004 .

[13]  J. S. Ard,et al.  Laser-raman spectra of lactose , 1974 .

[14]  C. Lerk,et al.  Alterations of α-Lactose During DifferentialScanning Calorimetry , 1984 .

[15]  S. Bates,et al.  Quantifying amorphous content of lactose using parallel beam X-ray powder diffraction and whole pattern fitting. , 2001, Journal of pharmaceutical and biomedical analysis.

[16]  M. Angberg.  Lactose and thermal analysis with special emphasis on microcalorimetry , 1995 .

[17]  P. Paronen,et al.  Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[18]  Thomas Rades,et al.  Quantitative analysis of polymorphic mixtures of carbamazepine by Raman spectroscopy and principal components analysis , 2004 .

[19]  Giancarlo Fini,et al.  Applications of Raman spectroscopy to pharmacy , 2004 .

[20]  Steven E. J. Bell,et al.  Development of sampling methods for Raman analysis of solid dosage forms of therapeutic and illicit drugs , 2004 .

[21]  P. Darcy,et al.  Quantitative assessments of powder crystallinity: Estimates of heat and mass transfer to interpret isothermal microcalorimetry data , 1998 .

[22]  Hiromitsu,et al.  Effect of Surface Morphology of Carrier Lactose on Dry Powder Inhalation Property of Pranlukast Hydrate. , 1998 .

[23]  G. Zografi,et al.  The Quantitative Analysis of Crystallinity Using FT-Raman Spectroscopy , 1998, Pharmaceutical Research.

[24]  P. Stewart,et al.  Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. , 2003, International journal of pharmaceutics.

[25]  A. Saleki-Gerhardt,et al.  Assessment of disorder in crystalline solids , 1994 .

[26]  S. Magazù,et al.  Anomalous cryoprotective effectiveness of trehalose: Raman scattering evidences , 1999 .